Skip to main content Scroll Top

News

  • Home
  • Alzheimer
  • Clinical Trials on Alzheimer’s Disease (CTAD CHINA)
Most Viewed Posts
Clear Filters
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases
7 February 2025
The neuroprotective effect of a new photobiomodulation technique on Aβ25-35 peptide-induced toxicity dramatically impact gut microbiota dysbiosis
11 July 2019
Challenges in developing Geroscience trials
Challenges in developing Geroscience trials
19 August 2023
24 October 2023

Clinical Trials on Alzheimer’s Disease (CTAD CHINA)

Read the article

Jacques Touchon (MD, PhD), University of Montpellier and Guillaume Blivet (MPH), REGEnLIFE, France.

Share this article

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.